NP-Owned Med Spa Playbook 2026: 27 States, Three Models, and How Nurse Practitioners Are Building the Next Wave

The 2026 medical aesthetics market is not the same industry it was five years ago — and Nurse Practitioners are one of the central reasons. NPs are no longer just clinical staff inside physician-owned med spas; they are increasingly the owners, the operators, and the entrepreneurs driving the next wave of growth. American Association of Nurse Practitioners data tracks 27 states where NPs hold sufficient authority to own a med spa under at least one viable structure, and across those 27 states the structure varies in three discrete patterns that every NP entrepreneur needs to understand before they sign a lease, file an entity, or recruit a medical director.

This pillar is the synthesis. Over the past week, MedSpa Standards published six state-specific NP playbooks — California, New York, Texas, Florida, Arizona, and Georgia — each running about 4,000 words on the local rules, structures, supervision instruments, and launch timelines specific to that state. This national reference sits above all six and is designed for the NP who has not yet picked a state, the multi-state platform mapping expansion, or the existing single-state NP-owned practice ready to scale into a second market. Each section links to the underlying state-specific guide where the operational detail lives.

The 2026 NP-owned med spa landscape — 27 states, three models, $26B industry

The headline numbers tell the story. The American Med Spa Association's 2024 State of the Industry data shows the US med spa count grew from approximately 1,600 practices in 2010 to 9,520 by 2024, and forecast models put 2026 at 11,553 practices supporting more than 53,000 jobs. Total industry revenue is projected near $26.2B in 2026, up from $23.3B in 2025 — a compound growth rate roughly 3x the broader US healthcare services market. Inside that growth, Nurse Practitioners are a disproportionate share of new entrepreneurs, particularly in markets where wellness-led service mixes (hormone therapy, GLP-1 weight loss, IV vitamin therapy) sit naturally inside NP scope of practice.

Twenty-seven states permit NP ownership of a med spa under at least one viable structure. The structures are not equivalent. In roughly 22 of those 27, NPs hold Full Practice Authority and can own and operate a med spa independently — no supervising physician, no friendly-PC structure, no Management Services Agreement. In the remaining 5 of the 27 with NP-ownership permission, supervision or collaboration arrangements are required but NPs can still hold equity in the clinical entity. In states outside the 27 (the Restricted Practice cohort), NPs cannot own the clinical entity directly, but they can still build economically equivalent ownership through the friendly-PC + NP-owned MSO structure that has become the dominant model in California, Texas, Florida, and Georgia.

The structural choice is not optional — it is dictated by state law and the cost of getting it wrong is material. An NP who attempts to own a clinical entity directly in California, Texas, Florida, or Georgia without the friendly-PC + MSO structure is exposed to Corporate Practice of Medicine enforcement, fee-splitting penalties, and (in California after SB 351) attorney general action. An NP in Arizona or Colorado who unnecessarily builds a friendly-PC structure spends six figures and slows launch by months for no regulatory benefit. The first decision is which state you are in and which of the three models governs your build.

The 2026 environment is also more regulated than 2024 or 2025. Every state in the six-state cohort produced significant regulatory developments in the first five months of 2026 — covered in the 2026 state med spa regulatory changes pillar. In some cases (Georgia's May 7 GCMB Position Statement, Arizona's Board of Nursing Advisory Opinion update) the changes targeted NP-owned operations specifically. The 2026 launch playbook must integrate both the ownership framework and the regulatory layer. The casual-structure era is over.

Three NP practice authority models that govern ownership

The American Association of Nurse Practitioners classifies the 50 states (plus DC) into three practice-authority categories. Each category translates directly to a distinct med spa ownership structure. Understanding the model is the first step before any business decision.

Full Practice Authority — independent practice and prescribing

Full Practice Authority (FPA) states recognize NPs as independent providers. Once licensed and (in some states) past a transition-to-practice period, the NP can evaluate, diagnose, order tests, interpret results, initiate and manage treatments, and prescribe — including controlled substances — without physician supervision or a written collaborative agreement. Roughly 22 states plus the District of Columbia hold FPA status as of 2026: Arizona, Colorado, Washington, Oregon, New Mexico, Maine, Iowa, Idaho, Vermont, New Hampshire, Hawaii, Alaska, Wyoming, Montana, Rhode Island, Connecticut, Nevada, North Dakota, Nebraska, South Dakota, Maryland, Minnesota, Massachusetts, Utah, Kansas, and DC.

In FPA states, an NP can form a Professional LLC or Professional Corporation owned entirely by NPs (or another permitted equity structure under state law) and operate a med spa directly. No supervising physician is required. No friendly-PC structure is required. The NP signs treatment protocols, prescribes Botox and dermal filler, prescribes compounded semaglutide under appropriate sourcing, and operates the clinical practice as the responsible licensee.

Reduced Practice — collaborative agreement required

Reduced Practice states require NPs to maintain a written collaborative agreement (or equivalent supervisory instrument) with a licensed physician to perform certain clinical activities — typically prescribing, certain procedures, or controlled substance authorization. Roughly 14 states hold Reduced Practice status: New York, Illinois, Ohio, Pennsylvania, Wisconsin, Indiana, Kentucky, Arkansas, Louisiana, Mississippi, Alabama, West Virginia, New Jersey, and Delaware.

The ownership picture in Reduced Practice states is mixed. In some (Illinois, Ohio), an NP can own the clinical practice as the equity holder but must contract a collaborating physician separately. In others (New York), the state's underlying Corporate Practice of Medicine doctrine layers on top — even with an NP collaborative agreement, the medical procedure scope (Botox, filler, lasers) requires physician ownership of the clinical entity, and the NP operates through a friendly-PC + NP-owned MSO structure. The state-specific guides decode which version applies to each market.

Restricted Practice — supervision-required, physician-owned clinical entity

Restricted Practice states require active physician supervision of NP practice across more clinical categories and typically prohibit NP ownership of the clinical entity for medical (non-nursing) services. Roughly 14 states hold Restricted Practice status: California, Texas, Florida, Georgia, North Carolina, South Carolina, Tennessee, Missouri, Oklahoma, Virginia, Michigan, and limited-scope variants in several others.

In Restricted Practice states, the standard NP med spa structure is friendly-PC + NP-owned MSO: a physician-owned Professional Corporation holds the clinical license and contracts with the supervising medical director; an NP-owned Management Services Organization owns the brand, the lease, the equipment (under MSA terms), the marketing, and the non-clinical operations. Economic ownership of the brand sits with the NP through the MSO; clinical authority sits with the physician through the PC. Both entities operate at arm's length under a written Management Services Agreement.

Model A: Full Practice Authority — independent NP ownership (AZ + 21 other states)

The simplest model and, for NPs whose home state allows it, the most attractive starting point. Full Practice Authority states let an NP form a single entity, take the lease, hire staff, sign protocols, prescribe, and operate as the responsible licensee — no parallel physician structure, no shared decision rights, no MSA. The build is fast, the structure is cheap, and the operating economics flow entirely to the NP owner.

Arizona as the FPA benchmark

Arizona's ARS §32-1601 grants Full Practice Authority broadly to qualified NPs from initial licensure, making it one of the most permissive FPA states in the country. An NP in Arizona can form an Arizona PLLC, open a med spa, sign treatment protocols, prescribe Schedule II–V controlled substances under DEA registration, and operate the entire clinical practice independently. The Arizona State Board of Nursing's 2025 Advisory Opinion update added a layer — written provider orders are now required for Level II and Level III medical aesthetic procedures — but the order can be the NP's own, signed in their capacity as the prescribing provider.

Our deep dive on Arizona NP med spa playbook 2026 covers the launch sequence, the 90-day timeline, the AZ Board of Nursing Advisory Opinion compliance overlay, and the state-specific licensure verification steps. For NPs who want to compare AZ to other FPA benchmarks, the broader Arizona state hub aggregates supplementary guides on full practice authority, scope of practice, and Arizona-specific inspection prep.

Colorado, Washington, Oregon, and the Pacific FPA cluster

Colorado, Washington, and Oregon follow the same FPA pattern with state-specific nuances. Colorado requires NPs to complete 1,000 documented mentored hours before transitioning to fully independent practice; once cleared, the structure mirrors Arizona. Washington allows independent practice from initial NP licensure but requires DEA registration for controlled substance prescribing. Oregon's NP practice is among the broadest in the country, recognized as functionally equivalent to physician practice for primary care and most outpatient settings, including aesthetic medicine.

The midwest and northeast FPA states

Iowa, Idaho, Maine, Vermont, New Hampshire, Connecticut, and Rhode Island all hold FPA status. Connecticut has seen growing NP-owned launch volume since its 2014 FPA grant. Massachusetts moved to FPA in 2021 (effective January 2022) and is now one of the larger FPA markets by economic activity. Maryland, Minnesota, Utah, Kansas, and DC complete the FPA roster with comparable structural advantages.

What FPA does not unlock

FPA recognizes NPs as independent providers within NP scope of practice; it does not extend NPs into procedures outside any NP's scope (most surgical procedures). For typical med spa services — Botox, filler, IV therapy, GLP-1, hormone therapy, laser hair removal, microneedling — FPA covers the entire menu in every state where it applies. For deeper aesthetic procedures (deep CO2 resurfacing, certain laser modalities), state-specific scope rules may layer on regardless of FPA status. Always check the state board of nursing's procedure list before launching that service line.

Model B: Reduced Practice — collaborative agreement required (NY, IL, OH, PA, and others)

The middle category. Reduced Practice states require a written collaborative agreement between the NP and a physician for certain clinical activities — but the structure varies enough across states that the practical implications differ materially. The collaborative agreement is the gating instrument, and its terms (signed protocols, supervision availability, chart review cadence, controlled substance authorization) define what the NP can actually do in practice.

New York — the 3,600-hour rule and the CPOM overlay

New York is the highest-volume Reduced Practice market and the one most NPs ask about. Education Law §6910, as amended by the NP Modernization Act, allows NPs to practice without a written collaborative agreement after completing 3,600 supervised practice hours — roughly two years of full-time practice. Below 3,600 hours, the NP requires a written practice agreement with a collaborating physician.

The 3,600-hour rule is widely misunderstood. It unlocks independence within nursing scope of practice — not within medical scope. New York's Corporate Practice of Medicine doctrine still applies to medical procedures: Botox, dermal filler, neuromodulators, energy-based devices including most lasers, and other procedures classified as the practice of medicine require a physician-owned clinical entity regardless of the NP's hours. The result: New York NPs operate med spas through a friendly-PC + NP-owned MSO structure, the 3,600-hour rule is mostly relevant for the NP's nursing-scope activities (e.g., IV therapy under certain rules, wellness consults), and the broader CPOM framework dictates ownership.

Our New York NP med spa playbook 2026 walks through the structural choices step by step, including the 3,600-hour eligibility audit, the friendly-PC formation, and the DOS task force compliance overlay introduced in January 2026. The New York state hub covers the related guides on NP supervision, advertising rules, and DOS inspection prep.

Illinois, Ohio, Pennsylvania — collaborative without CPOM overlay

Illinois, Ohio, and Pennsylvania all require collaborative agreements but their underlying CPOM doctrines are less restrictive than New York's. An NP in Illinois can own a Professional Service Corporation as the equity holder and contract a collaborating physician separately, without the friendly-PC overlay required in New York. Ohio's collaboration standard is somewhat looser, with consult-and-refer arrangements often sufficient. Pennsylvania falls between the two; the collaborative agreement is mandatory but ownership of the clinical entity by the NP is typically permitted.

What NPs in Reduced Practice states should plan for

Kentucky, Arkansas, Louisiana, Mississippi, Alabama, and West Virginia are smaller Reduced Practice markets with their own variations on the same template. Three universal items apply across every Reduced Practice state: (1) identify and contract a collaborating physician early, before lease signing — the supervision relationship is the gating dependency; (2) draft signed treatment protocols covering every service the NP will deliver, with the collaborating physician's countersignature; (3) document chart review cadence (monthly is standard) and maintain the chart review log as part of the inspection-ready binder. Skipping any one of these is the most common cause of regulatory exposure.

Model C: Restricted Practice — friendly-PC + NP-owned MSO (CA, TX, FL, GA, and others)

The most structured category and, for NPs in California, Texas, Florida, Georgia, and other Restricted Practice states, the only viable path to owning a med spa. The friendly-PC + NP-owned MSO structure has been the dominant model in these markets for over a decade. The 2026 environment has tightened how the structure can operate but not whether it can.

How the structure works mechanically

Two entities, two functions. The Professional Corporation (the "friendly-PC") is owned by a licensed physician (typically the medical director), holds the medical license, employs or contracts the clinical staff including the NP entrepreneur, and bills patients for clinical services. The Management Services Organization (the NP-owned MSO) is owned by the NP entrepreneur, owns or leases the facility, owns the brand and the equipment (under the MSA), provides administrative services to the PC — facility management, marketing, HR for non-clinical staff, IT, billing operations — and collects a fair-market-value management fee from the PC.

The arrangement is governed by a written Management Services Agreement that defines the scope of services, the fee structure, the term and termination, and the strict separation between clinical authority (PC) and administrative services (MSO). The MSA must reflect arm's-length terms. The management fee cannot vary based on clinical decisions or revenue allocations that suggest fee-splitting. Both entities maintain separate accounting, separate bank accounts, and separate governance.

California — SB 351 and the 104 NP exception

California is the strictest CPOM state and the most consequential for friendly-PC + MSO structure design. SB 351 (effective January 1, 2026) codified CPOM specifically against private equity firms, hedge funds, and the MSOs they control — prohibiting MSO clinical decision-making, voiding non-compete provisions in MSAs between PE-backed MSOs and PCs, and giving the Attorney General standing for injunctive relief. The law does not prohibit the friendly-PC + MSO structure itself; it tightens the operational discipline required to use it correctly.

California also has the 104 NP exception. Under AB-890, NPs who complete three years of standardized practice plus state-approved education can apply for the 104 NP designation and practice independently without physician supervision — including owning the clinical entity directly. 104 NPs can own and operate California med spas without the friendly-PC structure. Non-104 NPs (the vast majority of California NPs as of 2026) must still use friendly-PC + MSO. Our California NP med spa playbook 2026 walks through the 104 NP eligibility test, the SB 351 MSA audit, and the structural options for both pathways. The California state hub aggregates the supporting guides on AB-890, advertising rules, and inspection prep.

Texas — TMB Rule 169.28 and written delegation

Texas requires the friendly-PC + MSO structure plus written delegation through standing delegation orders, standing medical orders, protocols, or Physician Assistant Agreement equivalents (where applicable to specific procedures). TMB Rule 169.28, effective January 9, 2025, also imposes facility posting requirements — the delegating physician's name, TMB license number, and the TMB complaint notice must appear in every public area and treatment room — plus staff identification requirements. Our Texas NP med spa playbook 2026 walks through the delegation instrument selection, the facility posting compliance, and the 2026 staff ID rules. The Texas state hub covers the broader DSHS inspection prep and delegation framework.

Florida — AHCA Health Care Clinic Act

Florida requires the friendly-PC + MSO structure under the Corporate Practice of Medicine doctrine plus Health Care Clinic Act registration with AHCA (or qualifying exemption). NPs in Florida can own a med spa through the MSO structure with a physician-owned clinical entity; AHCA inspections target medical director presence, chart documentation, and facility compliance with the Health Care Clinic Act. Our Florida NP med spa playbook 2026 covers the AHCA registration decision tree, the medical director sourcing playbook, and the 2026 compliance overlay. The Florida state hub aggregates the supporting guides on AHCA inspection prep, DOH coordination, and Florida-specific delegation.

Georgia — GCMB Position Statement and matchmaker prohibition

Georgia requires the friendly-PC + MSO structure under its CPOM doctrine. The May 7, 2026 GCMB Position Statement expressly prohibits matchmaker medical director services — arrangements where a third-party platform collects a fee both for access to a delegating physician and for the physician's supervision compensation. NPs in Georgia must source the medical director through direct contract or legitimate physician staffing, not through prohibited matchmaker structures. Our Georgia NP med spa playbook 2026 walks through the medical director sourcing decision, the May 7 compliance audit, and the protocol agreement requirements. The Georgia state hub covers the broader protocol agreement and GDNA inspection framework.

State-by-state cohort summary: CA, NY, TX, FL, AZ, GA at a glance

Six state-specific NP playbooks published over the past week. The comparison table below summarizes the practice authority model, the dominant structure, the gating regulatory instrument, and the 2026 layer for each. Each row links to the underlying deep-dive guide and to the state's broader resource hub.

Arizona is the only Full Practice Authority state in the cohort and is included precisely as the FPA benchmark. NPs planning launch in any of the other 21 FPA states (Colorado, Washington, Oregon, and the rest) can read Arizona as the structural template and substitute state-specific licensure verification, board contact, and inspection prep details.

Six themes that cut across every state

Reading all six state playbooks together surfaces six recurring patterns that show up regardless of whether the state is FPA, Reduced, or Restricted. NPs preparing launch or expansion should design their compliance system to address all six up front.

1. Real supervision beats nominal supervision

Every 2026 state regulatory development — California's PSO shift, Arizona's written provider order rule, Texas's written delegation requirement, Georgia's "genuine clinical oversight" standard, New York's task force targeting ghost medical directors, Florida's AHCA citations on medical director gaps — pushes toward the same outcome. Whether the supervising provider is the NP themselves (FPA states) or a physician medical director (Restricted states), the supervision must be documented, current, and substantively visible in actual operations. The era of "supervisor on paper but absent in practice" is structurally ending across every state environment that moved in 2026. The underlying framework is covered in med spa medical director requirements and the deeper exposure analysis in medical director liability.

2. Per-patient documentation replaces standing-orders-only

California (Patient-Specific Orders), Arizona (written provider orders for Level II/III procedures), Texas (written delegation through one of four instruments), and Georgia (genuine clinical oversight implying patient-level documentation) all converge on the same operational outcome: every patient encounter requires individualized written authorization in the chart before delegated treatment. Standing orders covering "all qualifying patients" are no longer sufficient anywhere they were sufficient before. NP-owned practices in 2026 must build the GFE → Written Order → Treatment workflow into the EMR before launch.

3. Multi-agency enforcement is replacing siloed regulator action

New York's DOS-led task force is the most explicit example — a single inspection now generates parallel referrals across DOS, NYSED, OPMC, DOH, and the AG. The pattern shows up everywhere. Texas's TMB rule changes generate parallel BON and Board of Pharmacy enforcement. California's SB 351 enforcement runs through the AG with collateral Medical Board exposure. Georgia's GCMB statement targets practices the AG can also pursue. NP-owned operations planning compliance around a single regulator are exposed to enforcement they did not anticipate.

4. Federal enforcement now reaches individual operators

The FDA's April 2026 warning letter to Pure Indulgence Aesthetics in Texas was reportedly the first DSCSA warning letter targeting a dispenser-level med spa. Federal enforcement of DSCSA, prescription drug handling, FTC marketing substantiation, and HIPAA applies uniformly across every state regardless of state-level rules. NP-owned operations should treat federal compliance as a parallel vertical with its own documentation, audits, and accountability — not as a layer that someone else handles.

5. Service mix matters more than ever

NP-owned practices in FPA states are increasingly launching with wellness-led mixes (hormone therapy, GLP-1, IV vitamin therapy, skin care) first and adding injectables only when volume justifies the operational complexity. See hormone therapy compliance for med spas 2026 and the GLP-1 compliance complete guide for the service-line frameworks.

6. Documentation discipline is the universal competitive advantage

Every NP-owned practice that holds up under regulator scrutiny in 2026 has the same five-item documentation foundation: a signed Medical Director Agreement or equivalent supervision instrument; current treatment protocols with prescriber signatures; chart-review logs documenting actual review; on-site visit or telehealth supervision records; and license verifications for every clinical staff member. The cost of building this binder is trivial relative to launch cost. The cost of not building it is structural exposure across every state environment.

The multi-state NP entrepreneur's expansion playbook

For NPs already operating in one state and planning expansion into a second or third, the strategic question is not "can I" but "how do I structure once and have it work everywhere." Three principles emerge from the cohort patterns.

Build to the strictest state you touch

If your platform operates in Arizona (FPA) and California (Restricted + 104 NP), build the entire compliance chain to California's standard — PSO documentation, friendly-PC + MSO structure for non-104 NP operators, AB 1415 transaction discipline, SB 351 MSA hygiene. Arizona's requirements are a subset of California's; the California build covers both states. The reverse does not work: an Arizona-only build does not satisfy California requirements. The strictest-state-first principle saves the cost of rebuilding compliance later.

Maintain a single-source-of-truth documentation library

One master library of Medical Director Agreements, treatment protocols, written order templates, chart review logs, staff credential records, GFE templates, and consent forms. State-specific overlays handle the few items that vary — Arizona's written provider order format, Texas's facility posting and staff ID requirements, Georgia's protocol agreement structure, California's PSO documentation. The master library makes audit response and multi-state expansion both feasible. Our med spa policy and procedure manual guide covers the binder structure in detail.

Separate the brand from the clinical entities

For multi-state platforms operating across Restricted Practice states, each state needs its own friendly-PC. The NP-owned MSO can be a single multi-state entity (or a brand-holding parent with state-specific MSO subsidiaries) that contracts with each state's PC under a state-specific MSA. The brand, the marketing, the technology, and the operations live in the MSO layer; the clinical license and the medical director relationship live in each state's PC. This separation lets the NP entrepreneur build national brand equity while satisfying each state's CPOM doctrine.

Plan for state-specific medical director sourcing

Each Restricted Practice state requires a medical director licensed in that state. The medical director sourcing playbook differs materially across states. California's SB 351 environment rewards direct contracts and disfavors PE-backed staffing platforms. Georgia's May 7 GCMB Position Statement expressly prohibits matchmaker structures. Texas, Florida, and other states allow direct contracts and most legitimate staffing arrangements. NP entrepreneurs should build a medical director sourcing pipeline before they sign leases in new states — supervision is the gating dependency for launch in every Restricted Practice market.

Treat federal compliance as a separate vertical

FDA prescription drug handling, DEA controlled substance management, FTC marketing substantiation, DSCSA dispenser-level tracking, and HIPAA apply uniformly across every state. Build federal compliance as a separate vertical with its own documentation, audits, and accountability. The 2026 FDA Pure Indulgence warning letter is the canary — federal exposure is real and growing.

Service mix decisions across the NP-owned cohort

NP-owned med spas have a different service-mix center of gravity than physician-owned med spas. Three service categories sit naturally inside NP scope of practice and align with NP clinical interest: hormone therapy, GLP-1 / weight loss, and IV vitamin therapy. Injectables and energy-based devices also sit inside NP scope in most states but require more operational complexity to launch.

Hormone therapy as the NP entry service

Testosterone replacement therapy, bioidentical hormone replacement therapy, and broader hormone optimization are among the strongest growth categories in 2026 medical aesthetics. NPs hold deep clinical comfort with hormone management from primary-care backgrounds, the recurring-revenue model (monthly subscriptions, quarterly labs, semi-annual provider visits) supports stable cash flow, and the supervision overhead is lower than for injectables in most state environments. Schedule III controlled substance considerations apply for testosterone — every NP-owned hormone program needs DEA registration in the relevant state. See hormone therapy compliance for med spas 2026 for the complete TRT/HRT framework including 503A/503B compounding rules and FDA panel changes.

GLP-1 weight loss as the second wave

Semaglutide and tirzepatide compounded preparations remain a meaningful category for NP-owned med spas, though the 503A compounding landscape continues to tighten. Arizona's HB 4036 withdrawal in 2026 and the FDA's evolving position on compounded GLP-1 mean that NPs launching GLP-1 programs in 2026 need bulletproof sourcing documentation and current 503A-compliant compounding pharmacy relationships. See the GLP-1 compliance complete guide for the operational framework.

IV vitamin therapy as the wellness layer

IV vitamin therapy — Myers cocktails, NAD+, hydration, immunity blends — is high-margin, easy to scale, and squarely inside RN-delivered scope of practice with NP-signed protocols. The category is also growing under increased regulatory scrutiny. Texas's HB 3749 (Jenifer's Law) restricts IV administration to RN or above. Georgia's GCMB May 7 Position Statement clarified IV hydration supervision requirements. NP-owned operations should treat IV as a deliberately structured service line with written protocols, emergency procedures, and clear scope of delegation.

Injectables — Botox, dermal filler, neuromodulators

Injectables remain the highest-revenue-per-square-foot category in most med spa P&Ls but require the most operational complexity to launch correctly. Every state's GFE → consent → administration workflow must be tight; product sourcing must be DSCSA-compliant; the supervising provider's order or PSO must be in the chart before administration. NP-owned operations launching injectables-first should plan a 90-day launch ramp covering protocol authoring, product sourcing relationships, supervising-provider workflow integration, and staff training.

Energy-based devices and skin services

Laser hair removal, RF microneedling, IPL, and energy-based skin treatments sit in varied scope brackets. Some require physician supervision regardless of NP authority; others are delegable to RN-level operators. NP-owned operations should consult the state-specific scope chart before adding any energy-based service line. The med spa regulations by state reference covers the laser supervision framework across the eight highest-volume states.

The compliance system that works across state environments

Every NP-owned med spa that holds up under regulator scrutiny in 2026 — regardless of whether it operates in an FPA, Reduced, or Restricted Practice state — has the same documentation foundation. The list below is the universal floor; state-specific items layer on top per the individual state guides.

Documentation foundation (universal)

1. Supervision instrument — Medical Director Agreement (Restricted), Collaborative Practice Agreement (Reduced), or self-signed treatment protocols (FPA), current and on file
2. Treatment protocols — every service line covered by a signed protocol identifying the prescribing provider, the indications, contraindications, dosing, and emergency response
3. Chart review log — documented periodic chart review by the supervising provider (monthly is standard in Reduced/Restricted states; FPA states still benefit from internal QA review)
4. License verifications — every clinical staff member's current state license verified, copied, and maintained in the binder
5. Inspection-ready binder — physical or digital binder structured so any state regulator can be handed the documentation within ten minutes of an unannounced visit

Workflow and operations (universal)

1. GFE → Written Order → Treatment workflow — every Level II/III treatment requires a documented Good Faith Exam and individualized written order before delegated treatment
2. Service menu audit — every procedure offered must be performed by personnel whose license authorizes it in that state; remove any mismatched service
3. Drug and injectable sourcing audit — manufacturer-authorized distributors only, lot tracking maintained, temperature monitoring documented, expired product disposal documented
4. Standing orders clarified as protocols — generic standing orders are now general clinical protocols; patient-level authorizations come through PSOs / written provider orders / written delegation per state
5. Staff training — every clinical staff member trained on the GFE → Written Order → Treatment sequence and on the documentation expectations

State-specific overlay items

1. California NP-owned operations — 104 NP eligibility audit, SB 351 MSA compliance, AB 1415 transaction discipline, PSO documentation in every chart
2. New York NP-owned operations — 3,600-hour audit, friendly-PC + MSO structure, service menu audited against DOS Med Spa Procedure Licensure Chart
3. Texas NP-owned operations — written delegation instrument current, physician posting in every public area and treatment room, staff ID compliance, PAA coverage where applicable
4. Florida NP-owned operations — Health Care Clinic Act registration or qualifying exemption, medical director display per pending Board of Medicine rule
5. Arizona NP-owned operations — written provider order templates per treatment category, GLP-1 compounded supply chain audit
6. Georgia NP-owned operations — exit any matchmaker supervisor arrangement per May 7 GCMB Position Statement, restructure to direct physician contract or legitimate staffing placement

For comprehensive baseline compliance documentation that applies across all six cohort states and across the broader 27-state NP-ownership footprint, see our med spa policy and procedure manual guide and the broader national inspection readiness guide.

What 2027 will likely bring for NP-owned med spas

Forward-looking NP entrepreneurs should plan for several themes to surface across state legislatures and regulatory bodies in 2027.

• More states moving toward Full Practice Authority — the AANP-tracked trend over the past decade has been one or two states per year transitioning from Restricted or Reduced to Full Practice Authority. Watch Pennsylvania, North Carolina, and Michigan as possible 2027 candidates based on legislative activity in 2025–2026.
• Tighter CPOM enforcement in Restricted Practice states — California's SB 351 model is replicable. Expect other strict-CPOM states (New York, Massachusetts in some form, possibly Illinois) to consider similar legislation targeting PE/MSO clinical control.
• State-specific NP scope expansion in aesthetic medicine — several state boards of nursing are reviewing whether to issue advisory opinions on NP scope for specific aesthetic procedures (laser modalities, energy devices, certain injectables). Arizona's 2025 Advisory Opinion is the model.
• Federal DSCSA enforcement expansion — the FDA's Pure Indulgence warning letter is unlikely to be the last. Expect more dispenser-level enforcement actions, particularly around counterfeit injectables and unauthorized distributor sourcing.
• Multi-agency enforcement adoption — New York's task force model is replicable and politically attractive. Expect other states with active consumer protection apparatus to consider similar structures.
• Service-line-specific regulation expansion — Texas's HB 3749 (IV therapy), Georgia's GCMB May 7 IV hydration rules, and Arizona's withdrawn HB 4036 (GLP-1) signal a trend of state-by-state service-line-specific regulation. NP-owned operations should plan for this regulatory pattern to continue.
• Federal NP scope expansion legislation — periodic federal efforts to expand NP scope (especially for federal benefits programs) continue. While federal action does not override state law for med spa operations, federal signaling often influences state legislatures.

Where to start: pick your state, your service mix, your timeline

For NPs reading this pillar as the first step toward launch, the structured decision sequence is the same across every market.

Step 1 — Determine your state's practice authority model

Identify whether your state is Full Practice Authority, Reduced Practice, or Restricted Practice. The state-specific cohort guides above cover six of the largest markets (CA, NY, TX, FL, AZ, GA). For other states, AANP's State Practice Environment map is the authoritative reference. The structural choice flows from the practice authority model.

Step 2 — Pick your structure

In FPA states, form a Professional LLC or Professional Corporation owned by you as the NP entrepreneur. In Reduced Practice states, identify whether the state requires a friendly-PC overlay (New York) or allows NP ownership of the clinical entity with a separate collaborative agreement (Illinois, Ohio); structure accordingly. In Restricted Practice states, build the friendly-PC + NP-owned MSO with a licensed physician as the PC owner and yourself as the MSO owner, plus a written Management Services Agreement.

Step 3 — Source your supervising provider

For Restricted Practice states, identify and contract your medical director before signing a lease. The medical director relationship is the gating dependency for everything else. Direct contracts and legitimate physician staffing are both acceptable in most states; avoid matchmaker structures per Georgia's May 7 GCMB Position Statement (with nationwide implications even outside Georgia). For Reduced Practice states, identify your collaborating physician under the same logic.

Step 4 — Pick your service mix

Map your initial service mix to your state's regulatory tolerance and your own clinical comfort. Wellness-led (hormone, GLP-1, IV) is the easier launch in FPA states. Injectables-led can work in Restricted Practice states where the medical director's presence supports procedure-dense menus. Add service lines deliberately rather than launching everything at once.

Step 5 — Build the compliance binder

Before opening doors, build the inspection-ready binder. Five items: supervision instrument, signed protocols, chart review log structure, license verifications, and the binder organization that lets a regulator be handed everything in ten minutes. Our med spa inspection guide covers the binder structure in detail.

Step 6 — Plan your 90-day launch ramp

Lease, build-out, equipment, hiring, EMR selection, marketing pre-launch, soft open, and the first wave of patient encounters typically span 60–120 days from structure formation. The cohort guides cover the timeline per market.

Step 7 — Plan year-two expansion

Once your first market is operationally stable, plan year-two moves: adding a service line, adding a second location, or expanding to a second state. The multi-state expansion playbook section above covers the framework for cross-state moves.

Summary

1. Twenty-seven states allow Nurse Practitioner ownership of med spas in 2026 under three discrete practice-authority models: Full Practice Authority (~22 states), Reduced Practice (~14 states), and Restricted Practice (~14 states)
2. In Full Practice Authority states, NPs can own and operate med spas independently — no supervising physician, no friendly-PC structure, no Management Services Agreement
3. In Reduced Practice states, NPs need a written collaborative agreement with a physician; ownership of the clinical entity varies by state
4. In Restricted Practice states, the clinical entity must be physician-owned; NPs participate through the friendly-PC + NP-owned MSO structure
5. The US med spa industry grew from approximately 1,600 practices in 2010 to 9,520 in 2024 and is projected to reach 11,553 in 2026 with revenue near $26.2B — NP entrepreneurs drive a meaningful share of new growth
6. Six state-specific NP playbooks (CA, NY, TX, FL, AZ, GA) cover the cohort markets in operational detail; this pillar is the synthesis above them
7. Six themes cut across every state: real supervision over nominal, per-patient documentation, multi-agency enforcement, federal enforcement reaching individuals, service-mix matters, and documentation discipline as universal competitive advantage
8. Multi-state expansion is feasible but requires building to the strictest state in the footprint, maintaining single-source-of-truth documentation, separating brand from clinical entities, and planning state-specific medical director sourcing
9. Wellness-led service mixes (hormone therapy, GLP-1, IV vitamin therapy) sit naturally inside NP scope and are the most common launch pattern in FPA states; injectables-led launches are more common in Restricted Practice states
10. The 2027 outlook includes more states moving toward FPA, more CPOM enforcement in Restricted states, expanded NP scope advisory opinions, continued federal DSCSA enforcement, and multi-agency enforcement adoption across additional states

Disclaimer: This article is for educational purposes only and does not constitute legal advice. NP practice authority classifications and state-specific ownership structures evolve as state nursing boards, medical boards, and legislatures update their rules. Verify current requirements with your state board of nursing, state medical board, or licensed healthcare attorney before structuring any med spa. State-specific guides linked throughout provide deeper analysis of each state's regulatory framework and operational implications.